Equities

Lion Corp

Lion Corp

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)1,571.00
  • Today's Change-2.00 / -0.13%
  • Shares traded1.78m
  • 1 Year change+7.27%
  • Beta-0.1895
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Lion Corporation is a Japan-based company mainly engaged in the manufacture and sale of consumable goods and industrial products. The Company operates in three business segments. The General Consumable Goods segment purchases and manufactures consumable goods, as well as sells its products through agent stores. This segment also involves pet food trading and over-the-counter management business. The Industrial Goods segment trades industrial products and kitchen cleanser. The Overseas segment manufactures and sells general consumable goods and chemical materials in overseas markets. The Company is also engaged in the design, construction and maintenance of the Company's equipment and the transportation of its products, the real estate, agency and welfare businesses.

  • Revenue in JPY (TTM)408.51bn
  • Net income in JPY20.26bn
  • Incorporated1918
  • Employees7.55k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Milbon Co Ltd49.59bn4.09bn99.95bn1.14k24.042.0615.672.02125.56125.561,523.591,467.690.8971.829.9643,495,830.007.3910.078.6211.7561.4564.698.2411.332.29--0.0049.235.586.30-28.25-2.3019.1310.26
Earth Corp165.11bn4.71bn116.60bn4.79k24.681.6012.210.7062212.73212.737,463.123,286.451.083.154.2734,484,130.003.333.866.977.7440.0039.753.072.540.8808--0.082757.963.94-2.65-22.65--22.660.5164
Arata Corp954.51bn10.57bn126.38bn2.89k11.271.068.290.1324310.96310.9628,063.403,295.323.0820.367.42329,939,200.003.413.197.576.889.849.971.110.99371.15123.930.245625.185.894.5925.538.3811.6718.25
Noevir Holdings Co Ltd63.91bn7.47bn182.74bn1.37k24.473.6221.092.86218.64218.641,871.041,476.180.84882.456.4646,716,380.0010.098.7211.919.8867.3166.0611.8912.213.69--0.0164103.982.301.581.11-0.4348-4.224.10
Pigeon Corp97.77bn6.43bn190.02bn3.62k29.052.2916.411.9453.7853.78817.56683.020.9163.235.1527,023,770.006.1610.057.5512.4348.2548.796.729.953.45--0.0093.82-0.4846-2.05-13.49-12.210.94672.25
PALTAC Corp1.16tn21.19bn272.29bn2.24k12.820.96859.820.2345337.16337.1618,479.424,462.722.3819.925.25519,160,000.004.344.697.508.397.497.681.821.941.43--0.0023.994.332.567.200.8661-10.836.69
Pola Orbis Holdings Inc171.30bn9.76bn333.85bn4.05k33.061.9318.671.9544.0744.07773.43755.160.84171.8810.5242,339,100.004.825.375.566.1881.8482.845.736.273.21--0.0003124.314.21-6.96-15.562.8712.16-8.25
Fancl Corp109.77bn8.32bn365.64bn1.28k40.944.2329.733.3368.5168.51904.24663.011.082.989.1186,027,430.008.207.9810.409.6366.9968.587.587.002.82--0.0052.357.03-1.9777.730.4219-7.932.53
Kobayashi Pharmaceutical Co Ltd172.97bn13.91bn443.32bn3.53k30.852.0121.082.56184.09184.092,307.552,821.320.65422.674.7448,943,410.005.268.016.4110.1854.7256.458.0412.242.21--0.005433.194.330.70371.582.4529.678.88
Lion Corp408.51bn20.26bn446.84bn7.55k21.811.5210.311.0972.0272.021,451.451,032.180.85843.765.8154,107,680.004.795.637.048.9345.3047.605.596.451.20--0.096331.013.312.88-33.34-10.609.215.39
Kose Corp315.24bn14.58bn487.65bn7.56k31.501.6518.601.55255.46255.465,524.984,892.200.84821.227.2441,709,980.004.24--5.41--69.99--5.00--2.78--0.0358--3.90---37.87------
Shiseido Co Ltd987.39bn10.01bn1.37tn30.54k136.392.0715.421.3825.0325.032,469.581,653.130.75391.596.1732,330,880.000.91332.911.344.3975.0673.511.213.520.7494--0.316275.17-8.84-2.33-36.41-18.75-10.635.92
Data as of Sep 20 2024. Currency figures normalised to Lion Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

20.07%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 31 May 202413.30m4.68%
MFS International (UK) Ltd.as of 31 Aug 202413.10m4.60%
The Vanguard Group, Inc.as of 04 Sep 20248.72m3.07%
Daiwa Asset Management Co. Ltd.as of 30 Aug 20246.23m2.19%
Nikko Asset Management Co., Ltd.as of 06 Sep 20244.53m1.59%
Norges Bank Investment Managementas of 31 Dec 20233.40m1.20%
BlackRock Fund Advisorsas of 05 Sep 20243.06m1.08%
Mitsubishi UFJ Asset Management Co., Ltd.as of 22 Jul 20241.98m0.70%
Dimensional Fund Advisors LPas of 05 Sep 20241.56m0.55%
Eurizon Capital SGR SpAas of 31 Jul 20241.22m0.43%
More ▼
Data from 30 Jun 2024 - 31 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.